Compounds > technetium tc 99m sestamibi

Page last updated: 2024-08-16

technetium tc 99m sestamibi and Graves Disease

technetium tc 99m sestamibi has been researched along with Graves Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lee, H; Patel, NR; Tamara, LA	1
Baldane, S; Evcen, R; Gedik, GK; Guler, I; Ipekci, SH; Kebapcilar, L	1
Balan, KK; Baltrop, AH; Wishart, GC	1

Other Studies

3 other study(ies) available for technetium tc 99m sestamibi and Graves Disease

Article	Year
99mTc Sestamibi Thyroid Scan in Amiodarone-Induced Thyrotoxicosis Type I. Clinical nuclear medicine, 2016, Volume: 41, Issue:7 Topics: Aged; Amiodarone; Antithyroid Agents; Graves Disease; Humans; Male; Methimazole; Potassium Channel Blockers; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Thyrotoxicosis	2016
A case of hypercalcaemic crisis secondary to coexistence of primary hyperparathyroidism and Graves' disease. Endocrine regulations, 2016, Oct-01, Volume: 50, Issue:4 Topics: Adenoma; Female; Graves Disease; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Middle Aged; Parathyroid Neoplasms; Parathyroidectomy; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Sestamibi; Thyroidectomy; Ultrasonography	2016
Delayed tc-99m sestamibi washout in graves' disease. Clinical nuclear medicine, 2003, Volume: 28, Issue:3 Topics: Adenoma; Diagnosis, Differential; Female; Graves Disease; Humans; Hyperparathyroidism; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Sestamibi	2003